Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786277 · ClinicalTrials.gov registry record · NA
Learning Alerts for Acute Kidney Injury
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 2,046
- Enrollment target
NCT02786277 is a NA study that has completed, run by Yale University. The registered enrollment target is 2,046 participants.
The verdict
NCT02786277, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,046 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether the use of uplift (also known as Conditional Average Treatment Effect - CATE) modeling to empirically identify patients expected to benefit the most from AKI alerting and to target AKI alerts to these patients will reduce the rates of AKI progression, dialysis, and mortality.
Interventions
- OTHER Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,046 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2025-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02786277
The ClinicalTrials.gov registry entry for NCT02786277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,046 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alert is the first listed.
NCT02786277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02786277 about?
NCT02786277 is a clinical study titled "Learning Alerts for Acute Kidney Injury". The primary objective of this study is to determine whether the use of uplift (also known as Conditional Average Treatment Effect - CATE) modeling to empirically identify patients expected to benefit the most from AKI alerting and to target AKI alerts to these patients will reduce the rates of AKI p...
What is the current status of trial NCT02786277?
This trial is currently completed. It is a NA study. The enrollment target is 2,046 participants. The study started on 2024-02-15. Estimated completion is 2025-05-03.
What interventions are being tested in trial NCT02786277?
The interventions under investigation include: Alert (OTHER).
Who is sponsoring clinical trial NCT02786277?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.